Hawk Ridge Capital Management LP Bio Rad Laboratories, Inc. Transaction History

Hawk Ridge Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$350.25 - $422.63 $35,025 - $42,263	100 Added 0.05%	214,376 $76.8 Million
Q2 2023 Aug 14, 2023	BUY	$359.49 - $486.4 $23.9 Million - $32.3 Million	66,500 Added 45.0%	214,276 $81.2 Million
Q1 2023 May 15, 2023	BUY	$418.69 - $503.0 $18 Million - $21.6 Million	42,990 Added 41.03%	147,776 $70.8 Million
Q4 2022 Feb 14, 2023	BUY	$351.71 - $456.01 $2.15 Million - $2.78 Million	6,100 Added 6.18%	104,786 $44.1 Million
Q3 2022 Nov 14, 2022	BUY	$412.59 - $563.26 $40.7 Million - $55.6 Million	98,686 New	98,686 $41.2 Million

458

18.2M

19.5K

13.9K

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.42B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

Get notified when there are updates to the investment portfolio of Hawk Ridge Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Hawk Ridge Capital Management LP with notifications on news.